<dl class="row">
<dt class="col-md-1">
  <ref_annee> 
     2021 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Kovacevic T, Kovacevic SV, Stanetic M, Kovacevic P, Miljkovic B. Impact of pharmacist's intervention on decreasing erlotinib interactions in the treatment of lung cancer patients in low resource settings. J Oncol Pharm Pract. 2021 Mar;27(2):350-358. doi: 10.1177/1078155220921545. Epub 2020 Apr 29. PMID: 32349642. 
  </ref>
  <a><pmid>PMID32349642   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2021 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Choukroun C, Leguelinel-Blache G, Roux-Marson C, Jamet C, Martin-Allier A, Kinowski JM, Le Guillou C, Richard H, Antoine V. Impact of a pharmacist and geriatrician medication review on drug-related problems in older outpatients with cancer. J Geriatr Oncol. 2021 Jan;12(1):57-63. doi: 10.1016/j.jgo.2020.07.010. Epub 2020 Aug 13. PMID: 32800700. 
  </ref>
  <a><pmid>PMID32800700   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2021 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Khadela A, Bhikadiya V, Vyas B. Impact of oncology pharmacist services on humanistic outcome in patients with breast cancer. J Oncol Pharm Pract. 2021 Jan 25:1078155220988333. doi: 10.1177/1078155220988333. Epub ahead of print. PMID: 33491576. 
  </ref>
  <a><pmid>PMID33491576   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2021 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Charra F, Philippe M, Herledan C, Caffin AG, Larbre V, Baudouin A, Schwiertz V, Vantard N, Labussiere-Wallet H, Ducastelle-Leprêtre S, Barraco F, Balsat M, Larcher MV, Salles G, Rioufol C, Ranchon F. Immunosuppression medication adherence after allogeneic hematopoietic stem cell transplant: Impact of a specialized clinical pharmacy program. J Oncol Pharm Pract. 2021 Mar 8:10781552211000115. doi: 10.1177/10781552211000115. Epub ahead of print. PMID: 33683151. 
  </ref>
  <a><pmid>PMID33683151   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2021 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Menz BD, Johnson JL, Gillard DF, Chong W, Ward MB. The Role of the Pharmacist in Optimizing Cancer Immunotherapy: A Retrospective Study of Nivolumab Adverse Events. J Pharm Pract. 2021 Jun;34(3):386-396. doi: 10.1177/0897190019872937. Epub 2019 Sep 5. PMID: 33969772. 
  </ref>
  <a><pmid>PMID33969772   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2021 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Savas M, Bayraktar-Ekincioglu A, Celebi N. An evaluation of cancer patients' opinions about use of opioid analgesics and the role of clinical pharmacist in patient education in Turkey. Int J Clin Pharm. 2021 Apr;43(2):375-382. doi: 10.1007/s11096-020-01098-x. Epub 2020 Aug 1. PMID: 32740850. 
  </ref>
  <a><pmid>PMID32740850   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2021 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Kandemir EA, Bayraktar-Ekincioglu A, Kilickap S. Assessment of adherence to cancer-associated venous thromboembolism guideline and pharmacist's impact on anticoagulant therapy. Support Care Cancer. 2021 Mar;29(3):1699-1709. 
  </ref>
  <a><pmid>PMID32776163   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2021 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Mashni OK, Nazer LH, Khalil HZ, Dalbah MI, Tuffaha HW, Rumman AT, Jaddoua SM. Impact of Clinical Pharmacy Services on Patient Management in the Chemotherapy Infusion Clinics: A 5-Year Study at a Comprehensive Cancer Center. J Pharm Pract. 2021 Mar 24:8971900211003446. 
  </ref>
  <a><pmid>PMID33759629   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2021 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Vives N, Milà N, Binefa G, Travier N, Farre A, Vidal C, Sattari M, Bagaria G, Garcia M. Role of community pharmacies in a population-based colorectal cancer screening program. Prev Med. 2021 Apr;145:106420. 
  </ref>
  <a><pmid>PMID33422578   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2021 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Lankford C, Dura J, Tran A, Lam SW, Naelitz B, Willner M, Geyer K. Effect of clinical pharmacist interventions on cost in an integrated health system specialty pharmacy. J Manag Care Spec Pharm. 2021 Mar;27(3):379-384. doi: 10.18553/jmcp.2021.27.3.379. PMID: 33645240. 
  </ref>
  <a><pmid>PMID33645240   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2021 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Shang J, Ning W, Gong J, Su D, Jia X, Wang Y. Impact of clinical pharmacist services on anticoagulation management of total joint arthroplasty: A retrospective observational study. J Clin Pharm Ther. 2021 Apr 27. doi: 10.1111/jcpt.13428. Epub ahead of print. PMID: 33904165. 
  </ref>
  <a><pmid>PMID33904165   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2020 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Lau KM, Saunders IM, Sacco AG, Barnachea LC. Evaluation of pharmacist interventions in a head and neck medical oncology clinic [published online ahead of print, 2020 Jan 14]. J Oncol Pharm Pract. 2020;1078155219897129. doi:10.1177/1078155219897129 
  </ref>
  <a><pmid>PMID31937188   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2020 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Moon JY, Lee Y, Han JM, et al. Effects of pharmacist interventions on reducing prescribing errors of investigational drugs in oncology clinical trials. J Oncol Pharm Pract. 2020;26(1):29-35. doi:10.1177/1078155219834723 
  </ref>
  <a><pmid>PMID30832556   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2020 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Zecchini C, Vo TH, Chanoine S, et al. Clinical, economic and organizational impact of pharmacist interventions on injectable antineoplastic prescriptions: a prospective observational study. BMC Health Serv Res. 2020;20(1):113. Published 2020 Feb 12. doi:10.1186/s12913-020-4963-7 
  </ref>
  <a><pmid>PMID32050957   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2020 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Su YJ, Yan YD, Wang WJ, Xu T, Gu ZC, Bai YR, Lin HW. Preliminary exploration on the role of clinical pharmacists in cancer pain pharmacotherapy. Ann Palliat Med. 2020 Sep;9(5):3070-3077. doi: 10.21037/apm-20-627. Epub 2020 Aug 4. PMID: 32787363. 
  </ref>
  <a><pmid>PMID32787363   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2020 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Park D, Patel S, Yum K, Smith CB, Tsao CK, Kim S. Impact of Pharmacist-Led Patient Education in an Ambulatory Cancer Center: A Pilot Quality Improvement Project. J Pharm Pract. 2020 Nov 6:897190020970770. doi: 10.1177/0897190020970770. Epub ahead of print. PMID: 33153388. 
  </ref>
  <a><pmid>PMID33153388   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2020 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Sebring EJ, Rudisill MA, Bates JS, Auten JJ, Urick BY, Clark SM. An Evaluation of the Effect of Pharmacist-Led Comprehensive Chemotherapy Consultation Services on Outpatient Appointment Adherence. J Manag Care Spec Pharm. 2020 Jun;26(6):723-727. doi: 10.18553/jmcp.2020.26.6.723. PMID: 32463774. 
  </ref>
  <a><pmid>PMID32463774   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2020 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Suzuki S, Horinouchi A, Uozumi S, Matsuyama C, Kamata H, Kaneko A, Yamaguchi M, Okudera H, Tahara M, Kawasaki T. Impact of outpatient pharmacy interventions on management of thyroid patients receiving lenvatinib. SAGE Open Med. 2020 Jun 12;8:2050312120930906. doi: 10.1177/2050312120930906. PMID: 32587691; PMCID: PMC7294491. 
  </ref>
  <a><pmid>PMID32587691   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2019 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Bates JS, Auten J, Sketch MR, Patel T, Clark SM, Morgan KP, Muluneh B,
McLaughlin JE, Pinelli NR, Foster MC, Amerine L. Patient engagement in first
cycle comprehensive chemotherapy consultation pharmacist services and impact on
patient activation. J Oncol Pharm Pract. 2019 Jun;25(4):896-902. doi:
10.1177/1078155219832644. Epub 2019 Feb 26. 
  </ref>
  <a><pmid>PMID30808278   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2019 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Lahrman R, Johnson A, Heaton PC, Frede SM, Schwartz R. Assessment of community pharmacists' confidence, foundational knowledge, and coordination of care activities in patients with cancer as a chronic condition. J Am Pharm Assoc (2003). 2019 Jul - Aug;59(4S):S106-S111.e2. doi: 10.1016/j.japh.2019.03.020. Epub 2019 May 22. 
  </ref>
  <a><pmid>PMID31126832   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2019 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Chen PZ, Wu CC, Huang CF. Clinical and economic impact of clinical pharmacist intervention in a hematology unit. J Oncol Pharm Pract. 2020;26(4):866‐872. doi:10.1177/1078155219875806 
  </ref>
  <a><pmid>PMID31566112   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2019 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Patel H, Gurumurthy P. Improving medication safety in oncology care: impact of clinical pharmacy interventions on optimizing patient safety. Int J Clin Pharm. 2019;41(4):981-992. doi:10.1007/s11096-019-00860-0 
  </ref>
  <a><pmid>PMID31240551   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2019 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Riu-Viladoms G, Carcelero San Martín E, Martín-Conde MT, Creus N. Drug interactions with oral antineoplastic drugs: The role of the pharmacist. Eur J Cancer Care (Engl). 2019;28(1):e12944. doi:10.1111/ecc.12944 
  </ref>
  <a><pmid>PMID30324634   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2019 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Uchida M, Suzuki S, Sugawara H, et al. A nationwide survey of hospital pharmacist interventions to improve polypharmacy for patients with cancer in palliative care in Japan. J Pharm Health Care Sci. 2019;5:14. Published 2019 Jul 3. doi:10.1186/s40780-019-0143-5 
  </ref>
  <a><pmid>PMID31308953   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2018 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Suzuki H, Suzuki S, Kamata H, Sugama Y, Demachi K, Ikegawa K, Igarashi T, Yamaguchi M. Impact of pharmacy collaborating services in an outpatient clinic on improving adverse drug reactions in outpatient cancer chemotherapy. J Oncol Pharm Pract. 2018 Sep 4:1078155218798138. doi: 10.1177/1078155218798138. [Epub ahead of print] 
  </ref>
  <a><pmid>PMID30180775   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2018 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Leary MH, Morbitzer K, Walston BJ, Clark S, Kaplan J, Waldron K, Valgus J,
Falato C, Amerine L. Evaluation of Targeted Pharmacist Interventions to Reduce
Length of Stay in an Acute Care Practice Model. Ann Pharmacother. 2019
May;53(5):471-477. doi: 10.1177/1060028018815064. Epub 2018 Nov 18. 
  </ref>
  <a><pmid>PMID30449133   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2018 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Chargualaf MJ, Giao TT, Abrahamson AC, Steeb D, Law M, Bates J, Nedi T, Muluneh B. Layered learning pharmacy practice model in Ethiopia. J Oncol Pharm Pract. 2019 Jan 7:1078155218820105. doi: 10.1177/1078155218820105. [Epub ahead of print] 
  </ref>
  <a><pmid>PMID30616470   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2018 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Clemmons AB, Alexander M, DeGregory K, Kennedy L. The Hematopoietic Cell
Transplant Pharmacist: Roles, Responsibilities, and Recommendations from the
ASBMT Pharmacy Special Interest Group. Biol Blood Marrow Transplant. 2018
May;24(5):914-922. doi: 10.1016/j.bbmt.2017.12.803. Epub 2017 Dec 29. Review. 
  </ref>
  <a><pmid>PMID29292057   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2018 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Barboza-Zanetti MO, Barboza-Zanetti AC, Rodrigues-Abjaude SA, Pinto-Simões B, Leira-Pereira LR. Clinical pharmacists' contributions to hematopoietic stem cell transplantation: A systematic review. J Oncol Pharm Pract. 2019
Mar;25(2):423-433. doi: 10.1177/1078155218782372. Epub 2018 Jun 11. 
  </ref>
  <a><pmid>PMID29890918   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2018 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Birand N, Boşnak AS, Diker Ö, Abdikarim A, Başgut B. The role of the pharmacist in improving medication beliefs and adherence in cancer patients. J Oncol Pharm Pract. 2019 Feb 20:1078155219831377. doi: 10.1177/1078155219831377. [Epub ahead of print] 
  </ref>
  <a><pmid>PMID30786821   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2017 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Defoe KD, Jupp J, Leslie T. Integration of clinical pharmacists into an
ambulatory, pediatric hematology/oncology/transplant clinic. J Oncol Pharm Pract.
2019 Apr;25(3):607-612. doi: 10.1177/1078155217752534. Epub 2018 Feb 16. 
  </ref>
  <a><pmid>PMID29451420   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2017 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Jackson K, Letton C, Maldonado A, Bodiford A, Sion A, Hartwell R, Graham A,
Bondarenka C, Uber L. A pilot study to assess the pharmacy impact of implementing
a chemotherapy-induced nausea or vomiting collaborative disease therapy
management in the outpatient oncology clinics. J Oncol Pharm Pract. 2019
Jun;25(4):847-854. doi: 10.1177/1078155218765629. Epub 2018 Mar 27. 
  </ref>
  <a><pmid>PMID29587608   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2017 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     San-Juan-Rodriguez A, Newman TV, Hernandez I, Swart ECS, Klein-Fedyshin M,
Shrank WH, Parekh N. Impact of community pharmacist-provided preventive services on clinical, utilization, and economic outcomes: An umbrella review. Prev Med.
2018 Oct;115:145-155. doi: 10.1016/j.ypmed.2018.08.029. Epub 2018 Aug 23. 
  </ref>
  <a><pmid>PMID30145351   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2016 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Crespo A, Tyszka M. Evaluating the patient-perceived impact of clinical
pharmacy services and proactive follow-up care in an ambulatory chemotherapy
unit. J Oncol Pharm Pract. 2016 Feb 23. pii: 1078155216634180. [Epub ahead of
print] 
  </ref>
  <a><pmid>PMID26911478   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2016 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Moulin SM, Eutrópio FJ, Souza JO, Busato FO, Olivieri DN, Tadokoro CE. The
role of clinical pharmacists in treatment adherence: fast impact in suppression
of chronic myeloid leukemia development and symptoms. Support Care Cancer. 2017
Mar;25(3):951-955. doi: 10.1007/s00520-016-3486-6. Epub 2016 Nov 19. 
  </ref>
  <a><pmid>PMID27866336   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2016 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Barbier A., Nguyen K. D. &amp; Bussières, J. F. (2017). Rôle et impact du pharmacien en oncologie: revue de la littérature. Journal de Pharmacie Clinique, 36(1), 7-26. 
  </ref>
  <a><pmid>LID272   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2016 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Ingram SJ, Kirkdale CL, Williams S, Hartley E, Wintle S, Sefton V, Thornley T.
Moving anticoagulation initiation and monitoring services into the community:
evaluation of the Brighton and hove community pharmacy service. BMC Health Serv
Res. 2018 Feb 7;18(1):91. doi: 10.1186/s12913-018-2901-8. 
  </ref>
  <a><pmid>PMID29415718   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2016 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Au B, Dersch-Mills D, Ghosh S, Jupp J, Chambers C, Cusano F, Danilak M.
Implementation of additional prescribing authorization among oncology pharmacists
in Alberta. J Oncol Pharm Pract. 2019 Apr;25(3):584-598. doi:
10.1177/1078155217752076. Epub 2018 Jan 16. 
  </ref>
  <a><pmid>PMID29338572   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2015 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Patel JM, Holle LM, Clement JM, Bunz T, Niemann C, Chamberlin KW. Impact of a pharmacist-led oral chemotherapy-monitoring program in patients with metastatic
castrate-resistant prostate cancer. J Oncol Pharm Pract. 2015 Oct 22. pii:
1078155215612541. [Epub ahead of print] 
  </ref>
  <a><pmid>PMID26493871   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2015 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Wang Y, Wu H, Xu F. Impact of Clinical Pharmacy Services on KAP and QOL in
Cancer Patients: A Single-Center Experience. Biomed Res Int. 2015;2015:502431.
doi: 10.1155/2015/502431. Epub 2015 Nov 30. 
  </ref>
  <a><pmid>PMID26697487   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2015 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Weil E, Oxencis C. Pharmacist collaborative practice agreement for the
management of anemia in malignant disease with erythropoiesis-stimulating agents.
Support Care Cancer. 2015 Aug;23(8):2507-13. doi: 10.1007/s00520-015-2745-2. Epub
2015 May 14. 
  </ref>
  <a><pmid>PMID25971214   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2015 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Mohammed MA, Moles RJ, Chen TF. Impact of Pharmaceutical Care Interventions on
Health-Related Quality-of-Life Outcomes: A Systematic Review and Meta-analysis.
Ann Pharmacother. 2016 Oct;50(10):862-81. doi: 10.1177/1060028016656016. Review. 
  </ref>
  <a><pmid>PMID27363846   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2015 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Bahnasawy SM, El Wakeel LM, Beblawy NE, El-Hamamsy M. Clinical
Pharmacist-Provided Services In Iron-Overloaded Beta-Thalassaemia Major Children:
A New Insight Into Patient Care. Basic Clin Pharmacol Toxicol. 2017
Apr;120(4):354-359. doi: 10.1111/bcpt.12695. Epub 2017 Feb 16. 
  </ref>
  <a><pmid>PMID27800664   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2015 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Bertsch NS, Bindler RJ, Wilson PL, Kim AP, Ward B. Medication Therapy
Management for Patients Receiving Oral Chemotherapy Agents at a Community
Oncology Center: A Pilot Study. Hosp Pharm. 2016 Oct;51(9):721-729. 
  </ref>
  <a><pmid>PMID27803501   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2015 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Edwards Z, Ziegler L, Craigs C, Blenkinsopp A, Bennett MI. Pharmacist
educational interventions for cancer pain management: a systematic review and
meta-analysis. Int J Pharm Pract. 2019 Aug;27(4):336-345. doi:
10.1111/ijpp.12516. Epub 2019 Feb 1. Review. 
  </ref>
  <a><pmid>PMID30707465   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2015 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Tanaka K, Hori A, Tachi T, Osawa T, Nagaya K, Makino T, Inoue S, Yasuda M,
Mizui T, Nakada T, Goto C, Teramachi H. Impact of pharmacist counseling on
reducing instances of adverse events that can affect the quality of life of
chemotherapy outpatients with breast Cancer. J Pharm Health Care Sci. 2018 Apr
30;4:9. doi: 10.1186/s40780-018-0105-3. eCollection 2018. 
  </ref>
  <a><pmid>PMID29736254   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2015 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Fornasier G, Taborelli M, Francescon S, Polesel J, Aliberti M, De Paoli P,
Baldo P. Targeted therapies and adverse drug reactions in oncology: the role of
clinical pharmacist in pharmacovigilance. Int J Clin Pharm. 2018
Aug;40(4):795-802. doi: 10.1007/s11096-018-0653-5. Epub 2018 May 21. 
  </ref>
  <a><pmid>PMID29785683   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2015 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Goedken AM, Butler CM, McDonough RP, Deninger MJ, Doucette WR. Continuous
Medication Monitoring (CoMM): A foundational model to support the clinical work
of community pharmacists. Res Social Adm Pharm. 2018 Jan;14(1):106-111. doi:
10.1016/j.sapharm.2016.12.008. Epub 2017 Jan 2. 
  </ref>
  <a><pmid>PMID28087207   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2014 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Edwards SJ, Abbott R, Edwards J, LeBlanc M, Dranitsaris G, Donnan J, Laing K, Whelan MA, MacKinnon NJ. Outcomes assessment of a pharmacist-directed seamless care program in an ambulatory oncology clinic. J Pharm Pract. 2014 Feb;27(1):46-52. 
  </ref>
  <a><pmid>PMID24065784   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2014 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Leveque D, Delpeuch A, Gourieux B. New anticancer agents: role of clinical
pharmacy services. Anticancer Res. 2014 Apr;34(4):1573-8. 
  </ref>
  <a><pmid>PMID24692684   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2014 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Van Den Broucke J, Verhaeghe A, Debruyne PR, Verhelle K. [(Added) Value of a clinical pharmacist in the oncology department and optimalisation of the applicability of geriatric tools assessing potential inappropriate medication use in geriatric patients (Drug Burden Index and de Beers criteria)]. J Pharm Belg. 2014 Mar;(1):28-36. 
  </ref>
  <a><pmid>PMID24804391   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2014 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Selcuk A, Sancar M, Okuyan B, Demirtunc R, Izzettin FV. The potential role of clinical pharmacists in elderly patients during hospital admission. Pharmazie.2015 Aug;70(8):559-62. PubMed PMID: 26380527. 
  </ref>
  <a><pmid>PMID26380527   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2014 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Lam MS, Cheung N. Impact of oncology pharmacist-managed oral anticancer
therapy in patients with chronic myelogenous leukemia. J Oncol Pharm Pract. 2015 Sep 28. pii: 1078155215608523. [Epub ahead of print] 
  </ref>
  <a><pmid>PMID26419691   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2014 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Randolph LA, Walker CK, Nguyen AT, Zachariah SR. Impact of pharmacist interventions on cost avoidance in an ambulatory cancer center. J Oncol Pharm Pract. 2016 Sep 27. pii: 1078155216671189. 
  </ref>
  <a><pmid>PMID27682600   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2014 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Periasamy U, Mohd Sidik S, Rampal L, Fadhilah SI, Akhtari-Zavare M, Mahmud R. Effect of chemotherapy counseling by pharmacists on quality of life and
psychological outcomes of oncology patients in Malaysia: a randomized control
trial. Health Qual Life Outcomes. 2017 May 15;15(1):104. doi:
10.1186/s12955-017-0680-2. 
  </ref>
  <a><pmid>PMID28506305   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2013 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Delpeuch A, Leveque D, Gourieux B, Herbrecht R. Impact of clinical pharmacy
services in a hematology/oncology inpatient setting. Anticancer Res. 2015
Jan;35(1):457-60. 
  </ref>
  <a><pmid>PMID25550587   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2013 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Nightingale G, Hajjar E, Swartz K, Andrel-Sendecki J, Chapman A. Evaluation of a pharmacist-led medication assessment used to identify prevalence of and associations with polypharmacy and potentially inappropriate medication use among ambulatory senior adults with cancer. J Clin Oncol. 2015 May 1;33(13):1453-9. doi: 10.1200/JCO.2014.58.7550. Epub 2015 Mar 23. 
  </ref>
  <a><pmid>PMID25800766   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2013 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Ashjian E, Salamin LB, Eschenburg K, Kraft S, Mackler E. Evaluation of
outpatient medication reconciliation involving student pharmacists at a
comprehensive cancer center. J Am Pharm Assoc (2003). 2015 Sep-Oct;55(5):540-5.
doi: 10.1331/JAPhA.2015.14214. 
  </ref>
  <a><pmid>PMID26359964   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2013 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Keat CH, Sooaid NS, Yun CY, Sriraman M. Improving safety-related knowledge, attitude and practices of nurses handling cytotoxic anticancer drug: pharmacists' experience in a general hospital, Malaysia. Asian Pacific Journal of Cancer Prevention. 2013;14(1):69-73 
  </ref>
  <a><pmid>PMID23534806   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2013 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Ise Y, Morita T, Katayama S, Kizawa Y. The activity of palliative care team pharmacists in designated cancer hospitals: a nationwide survey in Japan. J Pain Symptom Manage. 2014 Mar;47(3):588-93. doi: 10.1016/j.jpainsymman.2013.05.008. Epub 2013 Sep 7. PubMed PMID: 24018207. 
  </ref>
  <a><pmid>PMID24018207   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2013 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Bazin C, Vieillard V, Astier A, Paul M. Implementation of real-time identification analysis and quantification of chemotherapies preparations with a Multispec(®) analyser. Ann Pharm Fr. 2014 Jan;72(1):33-40. doi: 10.1016/j.pharma.2013.09.006. Epub 2013 Oct 26. PubMed PMID: 24438667. 
  </ref>
  <a><pmid>PMID22941573   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2013 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Wilby KJ, Mohamad AA, AlYafei SA. Evaluation of clinical pharmacy services offered for palliative care patients in Qatar. J Pain Palliat Care Pharmacother. 2014 Sep;28(3):212-5. doi: 10.3109/15360288.2014.938884. Epub 2014 Jul 30. PubMed PMID: 25076019. 
  </ref>
  <a><pmid>PMID25076019   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2013 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Han JM, Ah YM, Suh SY, Jung SH, Hahn HJ, Im SA, Lee JY. Clinical and economic impact of pharmacists' intervention in a large volume chemotherapy preparation
unit. Int J Clin Pharm. 2016 Oct;38(5):1124-32. doi: 10.1007/s11096-016-0339-9. 
  </ref>
  <a><pmid>PMID27365091   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2013 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Ribed A, Romero-Jiménez RM, Escudero-Vilaplana V, Iglesias-Peinado I,
Herranz-Alonso A, Codina C, Sanjurjo-Sáez M. Pharmaceutical care program for
onco-hematologic outpatients: safety, efficiency and patient satisfaction. Int J Clin Pharm. 2016 Apr;38(2):280-8. doi: 10.1007/s11096-015-0235-8. Epub 2015 Dec
29. 
  </ref>
  <a><pmid>PMID26715547   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2012 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Guédat MG, Gouraud A, Ramiah T, Demazière J, Delanoy B, Vial T, Leboucher G, Charpiat B. [Clinical pharmacy and pharmacovigilance over a period of nine years in hospital]. Therapie. 2012 May-Jun;67(3):243-50. 
  </ref>
  <a><pmid>PMID22874491   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2012 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Deliens C, Deliens G, Filleul O, Pepersack T, Awada A, Piccart M, Praet JP, Lago LD. Drugs prescribed for patients hospitalized in a geriatric oncology unit: Potentially inappropriate medications and impact of a clinical pharmacist. J Geriatr Oncol. 2016 May 26. pii: S1879-4068(16)30052-2. doi: 10.1016/j.jgo.2016.05.001. [Epub ahead of print] 
  </ref>
  <a><pmid>PMID27238734   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2012 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Merten JA, Shapiro JF, Gulbis AM, Rao KV, Bubalo J, Lanum S, Engemann AM, Shayani S, Williams C, Leather H, Walsh-Chocolaad T. Utilization of Collaborative Practice Agreements between Physicians and Pharmacists as a Mechanism to Increase Capacity to Care for Hematopoietic Stem Cell Transplant Recipients. Biol Blood Marrow Transplant. 2013 Apr;19(4):509-18. doi: 10.1016/j.bbmt.2012.12.022. Epub 2013 Feb 15. 
  </ref>
  <a><pmid>PMID23419976   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2012 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Geissler K. A shared fight against cancer: the complementary roles of oncology physicians and oncology pharmacists. Expert Rev Anticancer Ther. 2013 Jan;13(1):13-5. doi: 10.1586/era.12.143. 
  </ref>
  <a><pmid>PMID23259422   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2012 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Patterson CJ. Best practices in specialty pharmacy management. J Manag Care Pharm. 2013 Jan-Feb;19(1):42-8 
  </ref>
  <a><pmid>PMID23383699   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2012 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Penm J, Li Y, Zhai S, Hu Y, Chaar B, Moles R. The impact of clinical pharmacy services in China on the quality use of medicines: a systematic review in context of China's current healthcare reform. Health Policy Plan. 2014 Oct;29(7):849-872.Epub 2013 Sep 19. Review. PubMed PMID: 24056897 
  </ref>
  <a><pmid>PMID24056897   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2012 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Yap KY, Low HX, Koh KS, Un M, Shih V, Chan A. Feasibility and acceptance of a pharmacist-run tele-oncology service for chemotherapy-induced nausea and vomiting
in ambulatory cancer patients. Telemed J E Health. 2013 May;19(5):387-95 
  </ref>
  <a><pmid>PMID23531095   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2012 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Mousavi M, Hayatshahi A, Sarayani A, Hadjibabaie M, Javadi M, Torkamandi H, Gholami K, Ghavamzadeh A. Impact of clinical pharmacist-based parenteral nutrition service for bone marrow transplantation patients: a randomized clinical trial. Support Care Cancer. 2013 Dec;21(12):3441-8. doi: 10.1007/s00520-013-1920-6. Epub 2013 Aug 16. Erratum in: Support Care Cancer. 2013 Dec;21(12):3449. PubMed PMID: 23949839. 
  </ref>
  <a><pmid>PMID23949839   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2012 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Chen J, Lu XY, Wang WJ, Shen B, Ye Y, Jiang H, Wang QS, Cheng B. Impact of a clinical pharmacist-led guidance team on cancer pain therapy in China: a prospective multicenter cohort study. J Pain Symptom Manage. 2014 Oct;48(4):500-9. doi: 10.1016/j.jpainsymman.2013.10.015. Epub 2014 Apr 13. PubMed PMID: 24726204. 
  </ref>
  <a><pmid>PMID24726204   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2012 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Wang Y, Huang H, Zeng Y, Wu J, Wang R, Ren B, Xu F. Pharmacist-led medication education in cancer pain control: a multicentre randomized controlled study in Guangzhou, China. J Int Med Res. 2013 Oct;41(5):1462-72. doi: 10.1177/0300060513491170. Epub 2013 Aug 23. PubMed PMID: 23975860 
  </ref>
  <a><pmid>PMID23975860   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2012 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Suzuki S, Sakurai H, Kawasumi K, Tahara M, Saito S, Endo K. The impact of pharmacist certification on the quality of chemotherapy in Japan. Int J Clin Pharm. 2016 Oct;38(5):1326-35. doi: 10.1007/s11096-016-0374-6. Epub 2016 Aug 29. 
  </ref>
  <a><pmid>PMID27573721   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2012 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Neville H, Broadfield L, Harding C, Heukshorst S, Sweetapple J, Rolle M.
Chemotherapy Order Entry by a Clinical Support Pharmacy Technician in an
Outpatient Medical Day Unit. Can J Hosp Pharm. 2016 May-Jun;69(3):202-8. Epub
2016 Jun 30. 
  </ref>
  <a><pmid>PMID27402999   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2011 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Yeoh TT, Si P, Chew L. The impact of medication therapy management in older oncology patients. Support Care Cancer. 2013 May;21(5):1287-93 
  </ref>
  <a><pmid>PMID23179492   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2011 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Ryan N, Chambers C, Ralph C, England D, Cusano F. Evaluation of clinical pharmacists' follow-up service in an oncology pain clinic. J Oncol Pharm Pract. 2012 Sep 27. 
  </ref>
  <a><pmid>PMID23019117   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2011 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Bourne RS, Choo CL. Pharmacist proactive medication recommendations using electronic documentation in a UK general critical care unit. Int J Clin Pharm. 2012 Apr;34(2):351-7. 
  </ref>
  <a><pmid>PMID22354852   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2011 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Jeanneret LA, Schneider MP, Troxler S, Bugnon O, Lüthi F. [Therapeutic adherence to oral cancer therapy and interdisciplinary management]. Rev Med Suisse. 2011 May 25;7(296):1154-8, 1160 
  </ref>
  <a><pmid>PMID21721207   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2011 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Walker SA, Lo JK, Compani S, Ko E, Le MH, Marchesano R, Natanson R, Pradhan R, Rzyczniak G, Teo V, Vyas A. Identifying barriers to medication discharge counselling by pharmacists. Can J Hosp Pharm. 2014 May;67(3):203-12. PubMed PMID: 24970940; PubMed Central PMCID: PMC4071082 
  </ref>
  <a><pmid>PMID24970940   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2011 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Valero García S, López Briz E, Escobar Cava P, Balaguer J, Pelufo A, Megías JE, Poveda Andrés JL. Selective ophthalmic intra-arterial melphalan therapy for advanced retinoblastoma: implementation and outcomes of a new chemotherapy protocol. J Oncol Pharm Pract. 2013 Jun;19(2):159-64. doi: 10.1177/1078155212457964. Epub 2012 Sep 25. PubMed PMID: 23014898 
  </ref>
  <a><pmid>PMID23014898   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2010 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Tuffaha HW, Abdelhadi O, Omar SA. Clinical pharmacy services in the outpatient pediatric oncology clinics at a comprehensive cancer center. Int J Clin Pharm. 2012 Feb;34(1):27-31. 
  </ref>
  <a><pmid>PMID22207272   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2010 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Valgus JM, Faso A, Gregory KM, Jarr S, Savage S, Caiola S, Walko CM, Kim J, Bernard SA. Integration of a clinical pharmacist into the hematology-oncology clinics at an academic medical center. Am J Health Syst Pharm. 2011 Apr 1;68(7):613-9. 
  </ref>
  <a><pmid>PMID21411803   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2010 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     McKee M, Frei BL, Garcia A, Fike D, Soefje SA. Impact of clinical pharmacy services on patients in an outpatient chemotherapy academic clinic. J Oncol Pharm Pract. 2011 Dec;17(4):387-94. doi: 10.1177/1078155210389217. Epub 2011 Jan 14. 
  </ref>
  <a><pmid>PMID21239453   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2010 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Sessions JK, Valgus J, Barbour SY, Iacovelli L. Role of oncology clinical pharmacists in light of the oncology workforce study. J Oncol Pract. 2010 Sep;6(5):270-2 
  </ref>
  <a><pmid>PMID21197195   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2010 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Chan A, Shih V, Chiang J, Chew L, Tay K, Quek R, Tao M, Lim ST. Clinical pharmacy services and research for lymphoma patients at a cancer center. J Oncol Pharm Pract. 2013 
  </ref>
  <a><pmid>PMID22706787   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2010 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Savage I, Blenkinsopp A, Closs SJ, Bennett MI. 'Like doing a jigsaw with half  the parts missing': community pharmacists and the management of cancer pain in the community. Int J Pharm Pract. 2013 Jun;21(3):151-60 
  </ref>
  <a><pmid>PMID23418926   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2009 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Flood KL, Carroll MB, Le CV, Brown CJ. Polypharmacy in hospitalized older adult cancer patients: experience from a prospective, observational study of an oncology-acute care for elders unit. Am J Geriatr Pharmacother. 2009 Jun;7(3):151-8. 
  </ref>
  <a><pmid>PMID19616183   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2009 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Crews KR, Cross SJ, McCormick JN, Baker DK, Molinelli AR, Mullins R, RellingMV, Hoffman JM. Development and implementation of a pharmacist-managed clinical
pharmacogenetics service. Am J Health Syst Pharm. 2011 Jan 15;68(2):143-50. doi: 
10.2146/ajhp100113. PubMed PMID: 21200062; PubMed Central PMCID: PMC3228517. 
  </ref>
  <a><pmid>PMID21200062   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2009 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Valgus J, Jarr S, Schwartz R, Rice M, Bernard SA. Pharmacist-led, interdisciplinary model for delivery of supportive care in the ambulatory cancer clinic setting. J Oncol Pract. 2010 Nov;6(6):e1-4 
  </ref>
  <a><pmid>PMID21358943   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2009 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Chung C, Collins A, Cui N. Development and implementation of an interdisciplinary oncology program in a community hospital. Am J Health Syst Pharm. 2011 Sep 15;68(18):1740-7. doi: 10.2146/ajhp100626. 
  </ref>
  <a><pmid>PMID21880891   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2009 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Iihara H, Ishihara M, Matsuura K, Kurahashi S, Takahashi T, Kawaguchi Y, Yoshida K, Itoh Y. Pharmacists contribute to the improved efficiency of medical practices in the outpatient cancer chemotherapy clinic. J Eval Clin Pract. 2012 Aug;18(4):753-60 
  </ref>
  <a><pmid>PMID21414113   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2009 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     O'Neal BC, Worden JC, Couldry RJ. Telepharmacy and bar-code technology in an i.v. chemotherapy admixture area. Am J Health Syst Pharm. 2009 Jul 1;66(13):1211-7. doi: 10.2146/ajhp080388. PubMed PMID: 19535660. 
  </ref>
  <a><pmid>PMID19535660   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2009 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     El Hajj MS, Hamid Y. Breast cancer health promotion in Qatar: a survey of community pharmacists' interests and needs. Int J Clin Pharm. 2013 Jun;35(3):376-85. doi: 10.1007/s11096-010-9449-y. Epub 2010 Nov 17. PubMed PMID: 21153487. 
  </ref>
  <a><pmid>PMID21153487   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2008 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Baniasadi S, Fahimi F, Shalviri G. Developing an adverse drug reaction reporting system at a teaching hospital. Basic Clin Pharmacol Toxicol. 2008 Apr;102(4):408-11. 
  </ref>
  <a><pmid>PMID18312492   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2008 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Delaney L, Chambers C, Roldán G, De Robles P, Cairncross G, Forsyth P, Easaw J. A feasibility study to assess the integration of a pharmacist into neurooncology clinic. J Oncol Pharm Pract. 2009 Jun;15(2):79-85 
  </ref>
  <a><pmid>PMID19036905   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2008 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Coutsouvelis J, Corallo CE, Dooley MJ, Foo J, Whitfield A. Implementation of a pharmacist-initiated pharmaceutical handover for oncology and haematology patients being transferred to critical care units. Support Care Cancer. 2010 Jul;18(7):811-6 
  </ref>
  <a><pmid>PMID19662439   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2008 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Khanal S, Poudel A, Sharan K, Palaian S. Oncology pharmacy practice in a teaching hospital in Nepal. J Oncol Pharm Pract. 2010 Jun;16(2):75-9. 
  </ref>
  <a><pmid>PMID19541763   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2008 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Tanguy-Goarin C, Mugnier N. L’activité de pharmacie clinique en hospitalisation continue d’oncologie et d’hématologie améliore significativement l’efficacité des actions pharmaceutiques et la prévention des problèmes pharmacothérapeutiques. Pharm Hosp. 2011;46 :4-12. 
  </ref>
  <a><pmid>LID187   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2007 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Bussières JF, Robelet A, Therrien R, Touzin K. Démarche pour la mise à niveau d'un secteur de soins pharmaceutiques : le cas de l'hématologie-oncologie pédiatrique. Can J Hosp Pharm. 2010 Mar;63(2):119-29 
  </ref>
  <a><pmid>PMID22478967   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2006 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Davies EC, Green CF, Mottram DR, Pirmohamed M. Adverse drug reactions in hospital in-patients: a pilot study. J Clin Pharm Ther. 2006 Aug;31(4):335-41. 
  </ref>
  <a><pmid>PMID16882102   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2006 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Le J, Nguyen T, Law AV, Hodding J. Adverse drug reactions among children over a 10-year period. Pediatrics. 2006 Aug;118(2):555-62. 
  </ref>
  <a><pmid>PMID16882807   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2006 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Ruder AD, Smith DL, Madsen MT, Kass FH 3rd. Is there a benefit to having a clinical oncology pharmacist on staff at a community oncology clinic? . J Oncol Pharm Pract. 2011 Dec;17(4):425-32. 
  </ref>
  <a><pmid>PMID21248174   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2006 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Chan A, Shih V, Chew L. Evolving roles of oncology pharmacists in Singapore: a survey on prescribing patterns of antiemetics for chemotherapy induced nausea and vomiting (CINV) at a cancer centre. J Oncol Pharm Pract. 2008 Mar;14(1):23-9. 
  </ref>
  <a><pmid>PMID18337437   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2005 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Bremberg ER, Hising C, Nylén U, Ehrsson H, Eksborg S. An evaluation of pharmacist contribution to an oncology ward in a Swedish hospital. J Oncol Pharm Pract. 2006 Jun;12(2):75-81. 
  </ref>
  <a><pmid>PMID16984745   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2005 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Jones KL, Barnett C, Gauthier M, Boster B, Espirito JL, Michaud LB. Clinical outcomes of a pharmacist-managed anticoagulation service for breast cancer patients. J Oncol Pharm Pract. 2012 Mar;18(1):122-7. 
  </ref>
  <a><pmid>PMID21364079   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2005 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Bussières JF, Théorêt Y, Prot-Labarthe S, Larocque D. Program to monitor surface contamination by methotrexate in a hematology-oncology satellite pharmacy. Am J Health Syst Pharm. 2007 Mar 1;64(5):531-5. 
  </ref>
  <a><pmid>PMID17322167   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2004 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Serrano-Fabiá A, Albert-Marí A, Almenar-Cubells D, Jiménez-Torres NV. Multidisciplinary system for detecting medication errors in antineoplastic chemotherapy. J Oncol Pharm Pract. 2010 Jun;16(2):105-12. 
  </ref>
  <a><pmid>PMID19617304   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2004 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     MacLeod A, Branch A, Cassidy J, McDonald A, Mohammed N, MacDonald L. A nurse-/pharmacy-led capecitabine clinic for colorectal cancer: results of a prospective audit and retrospective survey of patient experiences. Eur J Oncol Nurs. 2007 Jul;11(3):247-54. 
  </ref>
  <a><pmid>PMID17188937   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2004 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Díaz-Carrasco MS, Pareja A, Yachachi A, Cortés F, Espuny A. [Prescription errors in chemotherapy]. Farm Hosp. 2007 May-Jun;31(3):161-4. Spanish. 
  </ref>
  <a><pmid>PMID17941754   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2003 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Shah S, Dowell J, Greene S. Evaluation of clinical pharmacy services in a hematology/oncology outpatient setting. Ann Pharmacother. 2006 Sep;40(9):1527-33 
  </ref>
  <a><pmid>PMID16882869   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2002 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Serrano Fabiá A, Cavero Rodrigo E, Albert Marí A, Almenar Cubells D, Jiménez Torres NV. Pharmaceutical validation as a process of improving the quality of antineoplastic treatment. J Oncol Pharm Pract. 2005 Jun;11(2):45-50 
  </ref>
  <a><pmid>PMID16460604   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2002 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Xue Y, Schulman-Green D, Czaplinski C, Harris D, McCorkle R. Pain attitudes and knowledge among RNs, pharmacists, and physicians on an inpatient oncology service. Clin J Oncol Nurs. 2007 Oct;11(5):687-95. 
  </ref>
  <a><pmid>PMID17962176   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     1996 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Waddell JA, Solimando DA Jr, Strickland WR, Smith BD, Wray MK. Pharmacy staff interventions in a medical center hematology-oncology service. J Am Pharm Assoc (Wash). 1998 Jul-Aug;38(4):451-6. 
  </ref>
  <a><pmid>PMID9707955   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     1996 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Pon D. Service plans and clinical interventions targeted by the oncology pharmacist. Pharm Pract Manag Q. 1996 Apr;16(1):18-30. 
  </ref>
  <a><pmid>PMID10157737   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     1996 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Souvignier ST, Mayer JA, Eckhardt L. Educating the public about skin cancer prevention: a role for pharmacists. J Clin Pharm Ther. 1996 Dec;21(6):399-406. 
  </ref>
  <a><pmid>PMID9201566   </pmid></a> 
</dd> 
</dl>